SG10202100792XA - Non-human animals having a humanized cluster of differentiation 274 gene - Google Patents

Non-human animals having a humanized cluster of differentiation 274 gene

Info

Publication number
SG10202100792XA
SG10202100792XA SG10202100792XA SG10202100792XA SG10202100792XA SG 10202100792X A SG10202100792X A SG 10202100792XA SG 10202100792X A SG10202100792X A SG 10202100792XA SG 10202100792X A SG10202100792X A SG 10202100792XA SG 10202100792X A SG10202100792X A SG 10202100792XA
Authority
SG
Singapore
Prior art keywords
differentiation
gene
human animals
humanized
cluster
Prior art date
Application number
SG10202100792XA
Other languages
English (en)
Inventor
Elena Burova
Yajun Tang
Ka-Man Venus Lai
Andrew J Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG10202100792XA publication Critical patent/SG10202100792XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Humanized animals, e.g. knockin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
SG10202100792XA 2014-12-09 2015-12-09 Non-human animals having a humanized cluster of differentiation 274 gene SG10202100792XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462089549P 2014-12-09 2014-12-09
US201562106525P 2015-01-22 2015-01-22

Publications (1)

Publication Number Publication Date
SG10202100792XA true SG10202100792XA (en) 2021-03-30

Family

ID=55024286

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201703931QA SG11201703931QA (en) 2014-12-09 2015-12-09 Non-human animals having a humanized cluster of differentiation 274 gene
SG10202100792XA SG10202100792XA (en) 2014-12-09 2015-12-09 Non-human animals having a humanized cluster of differentiation 274 gene

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201703931QA SG11201703931QA (en) 2014-12-09 2015-12-09 Non-human animals having a humanized cluster of differentiation 274 gene

Country Status (23)

Country Link
US (3) US9913461B2 (fr)
EP (2) EP3230320B1 (fr)
JP (3) JP2018500896A (fr)
KR (2) KR102457921B1 (fr)
CN (2) CN107257624B (fr)
AU (2) AU2015360667B2 (fr)
BR (1) BR112017011982A2 (fr)
CA (1) CA2968675C (fr)
CY (1) CY1123723T1 (fr)
DK (1) DK3230320T3 (fr)
ES (1) ES2841353T3 (fr)
HR (1) HRP20202034T1 (fr)
HU (1) HUE052606T2 (fr)
IL (3) IL282649B (fr)
LT (1) LT3230320T (fr)
MX (1) MX2017007636A (fr)
PT (1) PT3230320T (fr)
RS (1) RS61218B1 (fr)
RU (1) RU2711729C2 (fr)
SG (2) SG11201703931QA (fr)
SI (1) SI3230320T1 (fr)
WO (1) WO2016094481A1 (fr)
ZA (1) ZA201703263B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018500896A (ja) * 2014-12-09 2018-01-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ヒト化分化抗原群２７４遺伝子を有する非ヒト動物
WO2017087780A1 (fr) 2015-11-20 2017-05-26 Regeneron Pharmaceuticals, Inc. Animaux non humains ayant un gène d'activation des lymphocytes 3 humanisé
MX2018009513A (es) 2016-02-04 2019-01-31 Regeneron Pharma Animales no humanos que tienen un gen angptl8 modificado genéticamente.
RU2749715C2 (ru) 2016-02-29 2021-06-16 Регенерон Фармасьютикалз, Инк. Грызуны, характеризующиеся гуманизированным геном tmprss
WO2018001241A1 (fr) 2016-06-28 2018-01-04 北京百奥赛图基因生物技术有限公司 Procédé de construction d'un modèle animal humanisé modifié par le gène pd-1 et son utilisation
US11317611B2 (en) 2016-08-31 2022-05-03 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric PD-L1
CN107815466B (zh) * 2016-08-31 2020-03-13 百奥赛图江苏基因生物技术有限公司 人源化基因改造动物模型的制备方法及应用
WO2018041120A1 (fr) 2016-08-31 2018-03-08 Beijing Biocytogen Co., Ltd Animal non humain génétiquement modifié avec un tigit humain ou chimérique
CN107815467B (zh) 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
MY191926A (en) 2016-12-01 2022-07-18 Regeneron Pharma Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
WO2019072241A1 (fr) 2017-10-13 2019-04-18 Beijing Biocytogen Co., Ltd Animal non humain génétiquement modifié avec pd-1 humain ou chimérique
CN109666701B (zh) * 2017-10-13 2021-08-24 百奥赛图(北京)医药科技股份有限公司 一种pd-1基因修饰人源化动物模型的构建方法及其应用
JP7361031B2 (ja) 2017-11-30 2023-10-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物
SG11202008620VA (en) 2018-03-26 2020-10-29 Regeneron Pharma Humanized rodents for testing therapeutic agents
EP3823443A1 (fr) 2018-07-16 2021-05-26 Regeneron Pharmaceuticals, Inc. Modèles animaux non humains de maladie ditra et leurs utilisations
CN110846321B (zh) * 2018-08-21 2021-11-19 中国科学院动物研究所 一种突变基因及其用于构建斑色鱼鳞癣小型猪模型的用途
US20210380978A1 (en) * 2018-10-15 2021-12-09 The Brigham And Women`S Hospital, Inc. The long non-coding RNA INCA1 and Homo sapiens heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) as therapeutic targets for immunotherapy
CN109452229B (zh) * 2018-11-19 2021-10-22 百奥赛图(北京)医药科技股份有限公司 狗源化pd-1基因改造动物模型的制备方法及应用
CN109979539B (zh) * 2019-04-10 2020-10-02 电子科技大学 基因序列优化方法、装置及数据处理终端
EP4294180A1 (fr) * 2021-02-19 2023-12-27 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Animal non humain génétiquement modifié ayant des gènes cd3 humains ou chimères
CN112999368A (zh) * 2021-04-09 2021-06-22 广东药康生物科技有限公司 人源化模型进行药效评价方法的建立

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US6485964B1 (en) * 1995-03-20 2002-11-26 Arris Pharmaceutical Corporation Transgenic mammals lacking expression of erythropoietin or of erythropoietin receptor, transgenic mammals expressing chimeric erythropoietin receptors, constructs for producing the transgenic mammals and uses therefor
GB9517780D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
EP1320599A2 (fr) 2000-06-28 2003-06-25 Genetics Institute, LLC Molecules pd-l2: nouveaux ligands pour pd-1 et leurs utilisations
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7794710B2 (en) 2001-04-20 2010-09-14 Mayo Foundation For Medical Education And Research Methods of enhancing T cell responsiveness
DE10211088A1 (de) * 2002-03-13 2003-09-25 Ugur Sahin Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP2206517B1 (fr) 2002-07-03 2023-08-02 Ono Pharmaceutical Co., Ltd. Compositions immunostimulantes contenant un anticorps anti-PD-L1
CA2507882A1 (fr) * 2002-12-16 2004-07-22 Genentech, Inc. Souris transgeniques exprimant le cd20 humain
ATE514713T1 (de) 2002-12-23 2011-07-15 Wyeth Llc Antikörper gegen pd-1 und ihre verwendung
EP2322637B1 (fr) 2003-12-24 2016-05-18 Novo Nordisk A/S Souris transgénique comprenant un polynucléotide codant pour un récepteur C5AR humain ou humanisé
ATE510020T1 (de) 2003-12-24 2011-06-15 G2 Inflammation Pty Ltd Transgenes nichtmenschliches säugetier mit einem polynukleotid, das für human-c5ar oder humanisiertes c5ar codiert
CA2583257C (fr) 2004-10-06 2017-01-17 Mayo Foundation For Medical Education And Research B7-h1 et procedes de diagnostic, de pronostic et de traitement du cancer
SI1802193T1 (sl) 2004-10-19 2014-08-29 Regeneron Pharmaceuticals, Inc. Postopek za generiranje miši, homozigotne za genetsko modifikacijo
AU2006265108C1 (en) 2005-07-01 2013-01-17 E. R. Squibb & Sons, L.L.C. Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
WO2007100098A1 (fr) 2006-03-03 2007-09-07 Kyoto University Multimere de domaine extracellulaire d'une molecule fonctionnelle de surface cellulaire
WO2010036959A2 (fr) 2008-09-26 2010-04-01 Dana-Farber Cancer Institute Anticorps anti-pd-1, pd-l1, et pd-l2 humains et leurs utilisations
CA2739902A1 (fr) 2008-10-08 2010-04-15 Intrexon Corporation Cellules modifiees exprimant des immuno-modulateurs multiples et leurs utilisations
CN112680475A (zh) * 2008-12-18 2021-04-20 伊拉兹马斯大学鹿特丹医学中心 表达人源化抗体的非人转基因动物及其用途
US8741295B2 (en) 2009-02-09 2014-06-03 Universite De La Mediterranee PD-1 antibodies and PD-L1 antibodies and uses thereof
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
WO2011020005A1 (fr) 2009-08-14 2011-02-17 Regeneron Pharmaceuticals, Inc. Cassette à auto-suppression dépendant de la différenciation régulée par un miarn
JP6109571B2 (ja) * 2009-08-28 2017-04-05 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 複数種のＣＣケモカインと結合するａｎｔｉｋｉｎｅ抗体
EP3056082B1 (fr) 2009-10-06 2018-09-05 Regeneron Pharmaceuticals, Inc. Souris génétiquement modifiées et greffe
WO2011060357A2 (fr) 2009-11-16 2011-05-19 The Ohio State University Cellules xénogéniques modifiées pour la réparation d'un tissu biologique
SI3279215T1 (sl) * 2009-11-24 2020-07-31 Medimmune Limited Usmerjena vezavna sredstva proti B7-H1
EP2516457B9 (fr) * 2009-12-21 2021-09-29 Regeneron Pharmaceuticals, Inc. Souris humanisees fc gamma r
US8507663B2 (en) * 2010-04-06 2013-08-13 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of CD274/PD-L1 gene
CN105861553B (zh) 2011-02-15 2020-08-14 再生元制药公司 人源化m-csf小鼠
RS59082B1 (sr) * 2011-10-28 2019-09-30 Regeneron Pharma Miševi sa genetski modifikovanim glavnim kompleksom gena tkivne podudarnosti
EP3696262A1 (fr) 2011-11-23 2020-08-19 The Trustees Of The University Of Pennsylvania Utilisation de cellules exprimant pdl1 pour convertir des lymphocytes t en lymphocytes t régulateurs
WO2013079174A1 (fr) 2011-11-28 2013-06-06 Merck Patent Gmbh Anticorps anti-pd-l1 et utilisations associées
CN111499755A (zh) 2012-08-03 2020-08-07 丹娜法伯癌症研究院 抗-pd-l1和pd-l2双结合抗体单一试剂及其使用方法
US20140047572A1 (en) * 2012-08-13 2014-02-13 University Of Rochester Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
PT4011915T (pt) 2012-08-21 2024-01-02 Regeneron Pharma Métodos para o tratamento ou prevenção da asma através da administração de um antagonista de il-4r
KR102473555B1 (ko) 2012-09-07 2022-12-05 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
US20140242077A1 (en) 2013-01-23 2014-08-28 Abbvie, Inc. Methods and compositions for modulating an immune response
EP3561050B1 (fr) 2013-02-20 2021-12-08 Regeneron Pharmaceuticals, Inc. Modification génétique de rats
SI2958938T1 (sl) * 2013-02-20 2019-08-30 Regeneron Pharmaceuticals, Inc. Miši, ki izražajo humanizirane koreceptorje za celice T
ES2949029T3 (es) * 2013-02-22 2023-09-25 Regeneron Pharma Células murinas que expresan complejo mayor de histocompatibilidad humanizado
ES2888250T3 (es) * 2013-04-16 2022-01-03 Regeneron Pharma Modificación direccionada del genoma de rata
CN103242448B (zh) * 2013-05-27 2015-01-14 郑州大学 一种全人源化抗pd-1单克隆抗体及其制备方法和应用
CA2913490A1 (fr) 2013-06-06 2014-12-11 Dana-Farber Cancer Institute, Inc. Compositions et procedes d'identification, d'evaluation, de prevention et de traitement du cancer en utilisant des isoformes pd-l1
TWI680138B (zh) * 2014-01-23 2019-12-21 美商再生元醫藥公司 抗ｐｄ-ｌ１之人類抗體
PL3157956T3 (pl) * 2014-06-19 2020-06-29 Regeneron Pharmaceuticals, Inc. Zwierzęta inne niż człowiek mające humanizowany gen zaprogramowanej śmierci komórkowej 1
JP2018500896A (ja) 2014-12-09 2018-01-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ヒト化分化抗原群２７４遺伝子を有する非ヒト動物
US11317611B2 (en) 2016-08-31 2022-05-03 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric PD-L1

Also Published As

Publication number Publication date
AU2015360667A1 (en) 2017-06-08
CN113412818A (zh) 2021-09-21
US20160157469A1 (en) 2016-06-09
JP2018500896A (ja) 2018-01-18
CY1123723T1 (el) 2022-03-24
RU2711729C2 (ru) 2020-01-21
LT3230320T (lt) 2021-01-11
JP2022184973A (ja) 2022-12-13
CN113412818B (zh) 2022-11-04
IL275864B (en) 2021-05-31
IL275864A (en) 2020-08-31
AU2015360667B2 (en) 2021-09-23
EP3808775A1 (fr) 2021-04-21
KR102316842B1 (ko) 2021-10-25
SG11201703931QA (en) 2017-06-29
CA2968675A1 (fr) 2016-06-16
CN107257624B (zh) 2021-07-13
US20180160663A1 (en) 2018-06-14
IL282649B (en) 2022-07-01
EP3808775B1 (fr) 2024-04-17
RU2017123754A3 (fr) 2019-06-24
JP2021003130A (ja) 2021-01-14
HRP20202034T1 (hr) 2021-02-19
SI3230320T1 (sl) 2021-02-26
RS61218B1 (sr) 2021-01-29
AU2021286369A1 (en) 2022-01-20
US20210105983A1 (en) 2021-04-15
KR102457921B1 (ko) 2022-10-25
IL282649A (en) 2021-06-30
CA2968675C (fr) 2023-10-17
US10881086B2 (en) 2021-01-05
ZA201703263B (en) 2023-02-22
EP3230320B1 (fr) 2020-10-07
CN107257624A (zh) 2017-10-17
ES2841353T3 (es) 2021-07-08
WO2016094481A1 (fr) 2016-06-16
PT3230320T (pt) 2021-01-08
RU2017123754A (ru) 2019-01-10
IL252695B (en) 2020-07-30
DK3230320T3 (da) 2021-01-11
KR20170101910A (ko) 2017-09-06
BR112017011982A2 (pt) 2018-01-16
EP3230320A1 (fr) 2017-10-18
JP7145920B2 (ja) 2022-10-03
KR20210130251A (ko) 2021-10-29
MX2017007636A (es) 2018-03-28
IL252695A0 (en) 2017-08-31
US9913461B2 (en) 2018-03-13
HUE052606T2 (hu) 2021-05-28

Similar Documents

Publication Publication Date Title
IL286403A (en) Non-human animals possess a humanized cluster of differentiation 47 gene
IL282649A (en) Non-human animals with a humanized gene for differentiation cluster 274
IL287519A (en) Non-human animals with a humanized programmed cell death gene 1
HK1253683A1 (zh) 具有人源化淋巴細胞活化基因3的非人動物